High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors

Sequential GemDMC-carboplatin/etoposide with or without ifosfamide shows outcomes that exceed the anticipated results in multiply, poor-risk relapsed GCT. Bevacizumab did not improve outcomes. See related commentary by Kollmannsberger et al., p. 257.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2025-08-25
DOI
https://doi.org/10.1158/1078-0432.ccr-25-1917
Citations
1
Primary Topic
Testicular diseases and treatments
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors

Peter F. Thall, Börje S. Andersson, Matthew T. Campbell, Shi‐Ming Tu et al.
1 citations
Clinical Cancer Research
Testicular diseases and treatments
2.01
article

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors

Peter F. Thall, Börje S. Andersson, Matthew T. Campbell, Shi‐Ming Tu, Andrew Johns, Irtiza Sheikh, Muzaffar H. Qazilbash, Amishi Y. Shah, Jeremy Ramdial, Roland L. Bassett, Yago L. Nieto, Terri Lynn Shigle, John Kent Lin, Ala Abudayyeh, Louis L. Pisters, John C. Araujo, John F. Ward, Elizabeth J. Shpall, Alison Gulbis, Uday Popat, J. Li, José A. Karam, Lance C. Pagliaro, David C. Rice, Jean‐Nicolas Vauthey, M. J. Barnett, Jianbo Wang, Roy B. Jones, Wayne L. Hofstetter
article en
1 citations

Abstract

Sequential GemDMC-carboplatin/etoposide with or without ifosfamide shows outcomes that exceed the anticipated results in multiply, poor-risk relapsed GCT. Bevacizumab did not improve outcomes. See related commentary by Kollmannsberger et al., p. 257.

Clinical Cancer ResearchVol. 32(2)
The University of Texas MD Anderson Cancer Center (US), Mayo Clinic in Arizona (US)
Openalex Percentile: Top 12%
Testicular diseases and treatments
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.